ASHG 2026 · Biopharma

Beren Therapeutics at ASHG 2026

Name: ASHG 2026 Annual Meeting
Start: 2026-10-20
End: 2026-10-24
Location: Montréal

Cedar Knolls, New Jersey

Beren Therapeutics at ASHG 2026 in Montréal: Booth 1810.

1810

exhibit booth

Explore everyone at ASHG 2026 →

Organization

ASHG 2026 Attendance

Beren Therapeutics

Cedar Knolls, New Jersey

berentx.com|LinkedIn

Beren develops cyclodextrin-based medicines and sponsors genomic testing for patients and families affected by Niemann-Pick disease type C.

Launched a national awareness and diagnostic program for Niemann-Pick disease type C, aiming to raise genetic testing and diagnosis rates.

›

Launched a national awareness and diagnostic program for Niemann-Pick disease type C, aiming to raise genetic testing and diagnosis rates.

2026-09 · source

Expanded its cyclodextrin patent portfolio to over 30 issued patents, strengthening its IP position ahead of a potential drug launch.

2026-08 · source

Secured $300 million in financing to prepare for a possible commercial launch of its drug adrabetadex.

2026-06 · source

Source: company newsroom

Raised $300M financing (Jun 2026)

›

Backers included Wellington Partners, JIC VGI, Founders Fund, Narya Capital, and Eisai. · 2026-06-10

“today announced it has secured $300 million in combined financing; including Wellington Partners, JIC Venture Growth Investments (JIC VGI), Founders Fund, Narya Capital, Eisai Co., Ltd.”

Source: funding announcement

Currently hiring

›

Source: careers page

Booth

Exhibiting at Booth 1810

Wed, Oct 219:45am–4:30pmThu, Oct 229:45am–1:30pmFri, Oct 239:45am–4:30pm

Meeting Beren Therapeutics in Montréal?

Get in-depth attendee and institution profiles and research, to plan your meetings in Montréal. Leave your work email and we’ll be in touch.

Not affiliated with or endorsed by the American Society of Human Genetics. Submit a correction